Evidence map›Paper›PMID 28174561›Full record

ArticleFrontiers in microbiology2017

A Framework for the Evaluation of Biosecurity, Commercial, Regulatory, and Scientific Impacts of Plant Viruses and Viroids Identified by NGS Technologies.

Sebastien Massart, Thierry Candresse, José Gil, Christophe Lacomme, Lukas Predajna, Maja Ravnikar, Jean-Sébastien Reynard, Artemis Rumbou, Pasquale Saldarelli, Dijana Škorić and 5 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sebastien MassartPlant Pathology Laboratory, Gembloux Agro-Bio Tech, University of Liège Gembloux, Belgium.
Thierry CandresseInstitut National de la Recherche Agronomique (INRA), University of Bordeaux, CS20032 UMR 1332 BFP Villenave d'Ornon, France.
José GilPlant Biology, Linnean Centre for Plant Biology, Uppsala BioCentre, Swedish University of Agricultural Sciences Uppsala, Sweden.
Christophe LacommeVirology and Zoology, Science and Advice for Scottish Agriculture Edinbourgh, UK.
Lukas PredajnaDepartment of Plant Virology, Institute of Virology, Biomedical Research Center, Slovak Academy of Science (SAS) Bratislava, Slovakia.
Maja RavnikarDepartment of Biotechnology and Systems Biology, National Institute of Biology Ljubljana, Slovenia.
Jean-Sébastien ReynardVirology, Agroscope Nyon, Switzerland.
Artemis RumbouDivision Phytomedicine Lentzeallee, Faculty of Life Sciences, Albrecht Daniel Thaer-Institute of Agricultural and Horticultural Sciences, Humboldt-University of Berlin Berlin, Germany.
Pasquale SaldarelliNational Research Council Institute for Sustainable Plant Protection Bari, Italy.
Dijana ŠkorićDepartment of Biology, Faculty of Science, University of Zagreb Zagreb, Croatia.
Eeva J VainioManagement and Production of Renewable Resources, Natural Resources Institute Finland (Luke) Helsinki, Finland.
Jari P T ValkonenDepartment of Agricultural Sciences, University of Helsinki Helsinki, Finland.
Hervé VanderschurenPlant Genetics, Gembloux Agro-Bio Tech, University of Liège Gembloux, Belgium.
Christina VarveriDepartment of Phytopathology, Benaki Phytopathological Institute Athens, Greece.
Thierry WetzelDLR Rheinpfalz, Institute of Plant Protection, Neustadt an der Weinstrasse Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in high-throughput sequencing technologies and bioinformatics have generated huge new opportunities for discovering and diagnosing plant viruses and viroids. Plant virology has undoubtedly benefited from these new methodologies, but at the same time, faces now substantial bottlenecks, namely the biological characterization of the newly discovered viruses and the analysis of their impact at the biosecurity, commercial, regulatory, and scientific levels. This paper proposes a scaled and progressive scientific framework for efficient biological characterization and risk assessment when a previously known or a new plant virus is detected by next generation sequencing (NGS) technologies. Four case studies are also presented to illustrate the need for such a framework, and to discuss the scenarios.

Indexed as

biological characterizationNGSpest risk analysisplant healthregulatory agenciesvirus diseases

Identifiers

PMID28174561
PMCPMC5258733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.